202653-44-9

Basic information

• Product Name: ((S)-3-Oxo-4-phenethyl-2,3,4,5-tetrahydro-pyrazin-2-yl)-acetic acid tert-butyl ester
• Synonyms: ((S)-3-Oxo-4-phenethyl-2,3,4,5-tetrahydro-pyrazin-2-yl)-acetic acid tert-butyl ester
• CAS NO: 202653-44-9
• Molecular Weight: 316.4
• Mol File: 202653-44-9.mol
• Article Data: 1

Chemical Properties

• CAS DataBase Reference: ((S)-3-Oxo-4-phenethyl-2,3,4,5-tetrahydro-pyrazin-2-yl)-acetic acid tert-butyl ester(CAS DataBase Reference)
• NIST Chemistry Reference: ((S)-3-Oxo-4-phenethyl-2,3,4,5-tetrahydro-pyrazin-2-yl)-acetic acid tert-butyl ester(202653-44-9)
• EPA Substance Registry System: ((S)-3-Oxo-4-phenethyl-2,3,4,5-tetrahydro-pyrazin-2-yl)-acetic acid tert-butyl ester(202653-44-9)

Safety Data

• Hazardous Substances Data: 202653-44-9(Hazardous Substances Data)

Upstream product

• 202653-31-4 (S)-3-Benzyloxycarbonylamino-N-(2,2-diethoxy-ethyl)-N-phenethyl-succinamic acid tert-butyl ester 
• 94508-09-5 N-(2-phenylethyl)aminoacetaldehyde diethyl acetal 
• 5545-52-8 Z-D(tBu)-OH 

Downstream Products

• 202653-32-5 ((S)-3-Oxo-4-phenethyl-piperazin-2-yl)-acetic acid tert-butyl ester 

Relevant articles and documents

Novel non-peptide fibrinogen receptor antagonists. 1. Synthesis and glycoprotein IIb-IIIa antagonistic activities of 1,3,4-trisubstituted 2- oxopiperazine derivatives incorporating side-chain functions of the RGDF peptide

Based on the lead tetrapeptide RGDF, two possible non-peptide glycoprotein (GP) IIb-IIIa antagonists possessing an (S)-2-oxopiperazine-3- acetic acid moiety as a scaffold incorporating the indispensable Asp fragment were prepared, and (S)-4-[[trans-[4-(gu